Skip navigation

Major Norwegian investment to finnish health tech sector - Evondos aims for international success

Briefing | Leena Manner | 11.12.2017

Finnish medication robotics company Evondos has reached a major agreement with Norwegian investing company Serendipity Partners. With this agreement Serendipity Partners makes a significant investment to Evondos and becomes a major owner in the company. New capital will help Evondos to strengthen the existing organization, invest significantly in exports, reaching new markets together with business and product development.

Evondos medicine dispensing robots provide significant help to home care daily work, both from home care customer’s welfare and from the economic point of view. Automation of medication distribution removes medicine misalignment and eases the burden of the home care staff. This can both provide better on-time medical care and cut costs significantly.

"Finnish health tech sector is enjoying rapid growth and international attention proves that both Evondos and Finland are doing right things. With new Norwegian owners onboard we can further strengthen our organization and also expect a rapid growth. This will mean new jobs and income both in Finland and in other Nordic countries, says Chairman of the Board of Evondos", Magnus Ehrnrooth. 

"Evondos automatic medicine dispensing service is already in use in many Norwegian and Finnish municipalities. Evondos is also present in Sweden and Denmark. New capital will improve our chances to grow in all of these markets, but also internationally."

Norwegian Serendipity Partners sees huge potential in both the developing health tech market and Evondos within it.

"We were impressed by both the know-how and the growth mindset of Evondos. It will be important also from Norwegian national perspective, that we have strong part to play in the developing hi-tech companies such as Evondos", says Director Michael Bodd from Serendipity Partners.

Evondos CEO Jyrki Niinistö is joyful for both the possibilities the investment opens for the company, but also for the society at large.

"With this investment Evondos has a chance to reach our ambitious goals. We are sure to see significant business benefits, but I’m sure the actual winners will be customers and their families. More and more people will have a chance to enjoy better medical care, and we can help hard-working home care staff to do their work even better. Also public sector will see benefits as better care can be provided with less costs."

More information:
Jyrki Niinistö 
CEO
+358 40 500 2881

Share article

More of this topic

Verdane partners with e-health company Evondos to improve home care of elderly in Nordics

Briefing, | Eetu Koski | 07.05.2020

Verdane, the specialist Northern European growth equity investor, has announced its investment in Evondos, the Finland-based Nordic leader in automated medicine dispensing services for elderly home care clients. Patient safety and the well-documented reliability of Evondos’ automated medicine dispensing service for independent living and improved medical adherence have made Evondos the partner of choice for over 200 regions and municipalities.

An end to flash drives, with remote upgrading of medicine-dispensing robots

Briefing | Suvi Rannikko | 25.11.2019

The firmware in Evondos medicine-dispensing robots will soon be upgraded remotely, with no further need for slow and cumbersome flash drive upgrades.

Kauppalehti tenth annual growth enterprise celebration: Evondos in southwest Finland shows fastest growth in 2018

Briefing | Leena Manner | 22.05.2019

The Finnish business newspaper Kauppalehti is arranging its tenth Growers tour in May 2019 covering the five districts of Oulu, Jyväskylä, Tampere, Turku and Helsinki, rewarding the top growth enterprises in each district.